CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 14461-14765 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/35349bb1fc9290338907b7d7f104c9db3951163b","sourcedb":"CORD-19","sourceid":"35349bb1fc9290338907b7d7f104c9db3951163b","text":"Different concentrations of atenolol gels in a hypomellose carrier and carbomer base were evaluated by an in vitro diffusion study using of treatment, transdermal atenolol was administered and blood samples were collected for atenolol serum concentrations at 3, 6, and 12 hours after topical application.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T102","span":{"begin":0,"end":304},"obj":"Sentence"},{"id":"T73137","span":{"begin":0,"end":304},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T102","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T73137","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T27","span":{"begin":193,"end":198},"obj":"Body_part"},{"id":"T28","span":{"begin":235,"end":240},"obj":"Body_part"}],"attributes":[{"id":"A27","pred":"uberon_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A28","pred":"uberon_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"subj":"T27","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T28","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93d7ec","default":true},{"id":"CORD-19-PD-UBERON","color":"#ece793"}]}]}}